Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alpha Teknova (TKNO) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Alpha Teknova (TKNO) over the last 6 years, with Q3 2025 value amounting to $3.2 million.

  • Alpha Teknova's Cash & Equivalents fell 4786.0% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 4786.0%. This contributed to the annual value of $3.7 million for FY2024, which is 8698.22% down from last year.
  • As of Q3 2025, Alpha Teknova's Cash & Equivalents stood at $3.2 million, which was down 4786.0% from $3.3 million recorded in Q2 2025.
  • In the past 5 years, Alpha Teknova's Cash & Equivalents registered a high of $108.0 million during Q2 2021, and its lowest value of $3.2 million during Q3 2025.
  • Its 5-year average for Cash & Equivalents is $37.7 million, with a median of $28.5 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 254006.03% in 2021, then plummeted by 8698.22% in 2024.
  • Quarter analysis of 5 years shows Alpha Teknova's Cash & Equivalents stood at $87.5 million in 2021, then tumbled by 51.74% to $42.2 million in 2022, then tumbled by 32.56% to $28.5 million in 2023, then crashed by 86.98% to $3.7 million in 2024, then dropped by 13.59% to $3.2 million in 2025.
  • Its Cash & Equivalents was $3.2 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.4 million in Q1 2025.